NERV

Valor Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM Total common shares outstanding 6.99 M6.99 M6.99 M6.99 M43.27 M — Enterprise value -5.83 M-5.4 M-3.22 M2.43 M91.66 M 85.48 M Price to earnings ratio 11.692.071.16-1.14-0.12 1.98 Price to sales ratio —0.480.49-445.89-601.6 -1 046.52 Price to cash flow ratio -0.86-0.73-0.83-1.12-2.52 -5.21 Price to book ratio -0.65-0.11-0.12-0.13-0.24 -0.6 Enterprise value to EBITDA ratio ————— — Return on assets % -0.12-0.11-0.11-0.1-2.9 -3.21 Return on equity % 0.170.130.10.082.02 2.33 Return on invested capital % ————-212.76 — Gross margin % 100100100100100 400 Operating margin % -43.55 K46.6 K15.98 K45.54 K23.92 K 132.04 K EBITDA margin % ————— — Net margin % -41.14 K44.81 K15.44 K43.93 K1.36 M 1.47 M Quick ratio ————— — Current ratio 7.859.216.154.8736.28 56.51 Inventory turnover ————— — Asset turnover 0-0-0-0-0 -0 Debt to assets ratio ————— — Debt to equity ratio ————— — Long term debt to total assets ratio ————— — Long term debt to total equity ratio ————— — Operating cash flow per share -0.68-0.54-0.27-0.39-0.53 -1.72 EBIT per share -0.6-0.52-0.45-0.38-0.59 -1.93 EBITDA per share ————— — Total debt per share ————— — Cash per share 2.822.282.011.629.72 15.65 Net current asset value per share 2.942.372.051.729.82 15.96 Tangible book value per share -5.36-5.82-6.21-6.53-18.39 -36.94 Working capital per share 2.572.111.721.379.55 14.75 Book value per share -3.39-3.85-4.24-4.57-16.63 -29.29